Skip to content

Radial Artery Versus Saphenous Vein Patency (RSVP) Study

A Randomised Controlled Trial to Compare Angiographic Patency of Radial Artery Versus Saphenous Vein Used as Free Aorto-coronary Grafts in Coronary Revascularization

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00139399
Acronym
RSVP
Enrollment
142
Registered
2005-08-31
Start date
1998-05-31
Completion date
2006-11-30
Last updated
2019-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Arteriosclerosis

Keywords

Coronary artery bypass, Coronary arteries, Atherosclerosis, Angiography, Blood flow

Brief summary

The purpose of this study is to determine whether the radial artery (artery in the arm) or saphenous vein (vein in the leg), when used as bypass grafts for coronary artery bypass surgery, have a greater patency rate (degree of opening)at 5 years after surgery.

Detailed description

Arteries differ from veins both in morphology and physiology. Thus the way they behave as in vivo conduits when used in coronary artery bypass grafting is also likely to be different. This may partly explain the predisposition of veins used as coronary conduits to accelerated atherosclerosis in comparison with the internal mammary artery grafts. There are presently few data describing the properties of the radial artery as an in-vivo coronary conduit over the longer-term. The study will compare angiographic patency of the radial artery or saphenous vein graft anastomosed to the native left circumflex coronary territory at 3 months and 5 years after surgery. A substudy will compare 5-year post-surgery diameter and blood flow of in-vivo radial artery and saphenous vein grafts in response to endothelium-dependent and non-endothelium-dependent stimuli when patients attend for their scheduled follow-up angiogram.

Interventions

PROCEDURECoronary artery bypass graft (CABG) surgery

Patients were randomized to receive either a radial artery or a long saphenous vein graft to the left circumflex coronary artery territory during CABG surgery

Sponsors

The Royal College of Surgeons of England
CollaboratorOTHER
Royal Brompton & Harefield NHS Foundation Trust
CollaboratorOTHER
National Heart Foundation, Australia
CollaboratorOTHER
Victor Phillip Dahdaleh Charitable Foundation
CollaboratorOTHER
Imperial College London
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* on waiting list for clinically-indicated myocardial revascularization surgery * aged 40-70 years * significant stenosis (≥70%) in the circumflex territory as identified on preoperative angiograms * negative Allen's test (defined as the return of palmar circulation within 5 seconds of releasing ulnar artery compression) * willing to give written informed consent

Exclusion criteria

* poor left ventricular (LV) function (LV ejection fraction \<25%) * severe diffuse peripheral vascular disease or bilateral varicose venous disease * inability to comply with the angiographic follow-up at 3 months or/and 5 years

Design outcomes

Primary

MeasureTime frameDescription
Patency Rates5 yearsAngiographic patency rates of radial artery and long saphenous vein grafts at follow-up angiography
Mean Diameter of the Study Graft (Saphenous Vein or Radial Artery)5 year follow-upDiameter response of the study vessel (saphenous vein or radial artery graft) to acetylcholine, measured using quantitative coronary angiography from the coronary angiogram.

Secondary

MeasureTime frameDescription
Blood Flow Volume5 yearsGraft flow response to acetylcholine, calculated from vessel diameter using quantitative coronary angiography, and velocity using an intragraft Doppler wire.

Countries

United Kingdom

Participant flow

Participants by arm

ArmCount
Saphenous Vein
Saphenous vein aortocoronary bypass graft Patients were randomized to receive a long saphenous vein graft to the left circumflex coronary artery territory during CABG surgery
60
Radial Artery
Radial artery aortocoronary bypass graft Patients were randomized to receive a radial artery graft to the left circumflex coronary artery territory during CABG surgery
82
Total142

Baseline characteristics

CharacteristicSaphenous VeinRadial ArteryTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
19 Participants14 Participants33 Participants
Age, Categorical
Between 18 and 65 years
41 Participants68 Participants109 Participants
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
2 Participants3 Participants5 Participants
Sex: Female, Male
Male
58 Participants79 Participants137 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
4 / 603 / 82
other
Total, other adverse events
0 / 600 / 82
serious
Total, serious adverse events
11 / 6013 / 82

Outcome results

Primary

Mean Diameter of the Study Graft (Saphenous Vein or Radial Artery)

Diameter response of the study vessel (saphenous vein or radial artery graft) to acetylcholine, measured using quantitative coronary angiography from the coronary angiogram.

Time frame: 5 year follow-up

Population: Intracoronary physiology investigations (diameter and intracoronary Doppler blood flow velocity measurements) were carried out in a subgroup of patients (n=27).

ArmMeasureValue (MEAN)Dispersion
Saphenous VeinMean Diameter of the Study Graft (Saphenous Vein or Radial Artery)3.18 mmStandard Deviation 0.67
Radial ArteryMean Diameter of the Study Graft (Saphenous Vein or Radial Artery)2.7 mmStandard Deviation 0.29
Primary

Patency Rates

Angiographic patency rates of radial artery and long saphenous vein grafts at follow-up angiography

Time frame: 5 years

Population: 103 of the patients randomized at the time of surgery agreed to return for the 5-year follow-up angiogram.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Saphenous VeinPatency RatesPatent graft38 Participants
Saphenous VeinPatency RatesOccluded graft6 Participants
Radial ArteryPatency RatesPatent graft58 Participants
Radial ArteryPatency RatesOccluded graft1 Participants
Secondary

Blood Flow Volume

Graft flow response to acetylcholine, calculated from vessel diameter using quantitative coronary angiography, and velocity using an intragraft Doppler wire.

Time frame: 5 years

Population: 27 of the patients who returned for the 5 year angiogram were eligible for invasive measurement of blood flow.

ArmMeasureValue (MEAN)Dispersion
Saphenous VeinBlood Flow Volume39 ml/minStandard Deviation 15
Radial ArteryBlood Flow Volume44 ml/minStandard Deviation 19

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026